At a glance
ClinicalIndex Comparison RecordN/ACompleted· 3,400 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of OCs Containing Dienogest and Risk of Venous Thromboembolism
Center for Epidemiology and Health Research, Germany·observational·Posted Aug 31, 2007·Updated Mar 23, 2010
In Brief
An observational study for Venous Thromboembolism. Completed, enrolled 3,400 participants across 1 site.
Detailed Summary
The objective of this study is to compare the risk of venous thromboembolism (VTE) of oral contraceptives with non-use, focusing specifically on Valette® compared to other users of low estrogen dose combined oral contraceptives.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsVenous Thromboembolism
CountriesGermany
CollaboratorsBayer
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2007
First PostedAug 2007
Study CompletionJun 2008
TodayJul 2026
First PostedAug 31, 2007
Enrollment StartJul 1, 2007
Study CompletionJun 1, 2008
TodayJul 2, 2026
Posted 18.8 years ago